AnalystsKostas BiliourisKostas Biliouris's Stock Forecasts
AnalystsKostas Biliouris
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4390 out of 4563 analysts
Average Return
-8.72%
Win Rate
30%9 out of 30
Risk vs Reward
Poor
Good
Kostas Biliouris's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Verve Therapeutics IncVERV | +57.31% | $12.65 | $19.90 | 2022-06-16 - 2023-06-16 | Buy |
Centessa Pharmaceuticals PLCCNTA | +52.80% | $4.28 | $6.54 | 2022-08-10 - 2023-08-10 | Buy |
Legend Biotech CorpLEGN | +51.57% | $46.23 | $70.07 | 2022-06-16 - 2023-06-16 | Buy |
Korro Bio IncKRRO | +33.74% | $47.10 | $62.99 | 2024-02-26 - 2024-04-24 | Buy |
Centessa Pharmaceuticals PLCCNTA | +32.49% | $7.14 | $9.46 | 2023-07-24 - 2024-04-24 | Buy |
Kostas Biliouris Analyst Color
Get additional color on Kostas Biliouris's coverage of popular stocks
Kostas Biliouris's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Centessa Pharmaceuticals PLCCNTA | 4 | Buy | $15.00 | +58.56% | Maintains | 24 days ago |
4d Molecular Therapeutics IncFDMT | 3 | Buy | $63.00 | +159.79% | Maintains | 24 days ago |
Beam Therapeutics IncBEAM | 3 | Buy | $57.00 | +150.66% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 3 | Buy | $234.00 | +62.73% | Maintains | a month ago |
Korro Bio IncKRRO | 2 | Buy | $120.00 | +90.51% | Reiterates | a month ago |
Metagenomi IncMGX | 1 | Buy | $22.00 | +225.93% | Initiates Coverage On | 2 months ago |
Sarepta Therapeutics IncSRPT | 1 | Buy | $170.00 | +36.82% | Initiates Coverage On | 3 months ago |
Bridgebio Pharma IncBBIO | 1 | Hold | $37.00 | +47.82% | Initiates Coverage On | 3 months ago |
Silence Therapeutics PLCSLN | 1 | Buy | $67.00 | +200.85% | Initiates Coverage On | 3 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $62.00 | +192.87% | Maintains | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $100.00 | +9.65% | Maintains | 6 months ago |
Prime Medicine IncPRME | 1 | Buy | $19.00 | +304.26% | Initiates Coverage On | 7 months ago |
Legend Biotech CorpLEGN | 2 | Buy | $90.00 | +99.25% | Maintains | a year ago |
Precision Biosciences IncDTIL | 2 | Hold | $120.00 | N/A | Downgrades | a year ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $7.00 | N/A | Downgrades | a year ago |
Verve Therapeutics IncVERV | 2 | Buy | $62.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $98.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.